公司资料
180 Life Sciences 股价、新闻与催化剂
- 股票代码:
- ATNF
- 交易所:
- NASDAQ
- 行业:
- Life Science Tools
- 所在地:
- United States
股价为何变动
目前无法获取 ATNF 的收盘价变动背景。
公司概览
业务概览
180 Life Sciences is a life-sciences company that has pursued multiple research and platform directions over time. Its identity has been shaped by strategic repositioning rather than a single durable therapeutic franchise.
所在地与行业分类
180 Life Sciences is headquartered in the United States and listed on NASDAQ. It sits in life sciences and biotech-adjacent development.
商业模式特征
The company depends on corporate strategy, capital management, and the ability to find a focused pipeline or business model. Investors generally watch restructuring, financing, and program selection.
生物医药行业定位
180 Life Sciences occupies a strategic-repositioning niche rather than a clear therapeutic franchise. Its stock tends to reflect whether management can sharpen the company's identity.
未来催化剂
- 180 Life Sciences is now mostly a legacy and closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it like an active development name.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。